In the liver, GCs promote hepatic gluconeogenesis [26], however, they reduce glucose uptake and utilization in skeletal muscle and white adipose tissue [27], which coordinately contribute to hyperglycemia and peripheral insulin resistance. This evidence concerns the gene INS and Hyperglycemia.